StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)

Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –

Prestige Consumer Healthcare price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Prestige Consumer Healthcare's price to sales ratio was 1.9× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.9× to 3.9×, with a median of 2.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×−0.8
2025Dec 31, 20252.8×−0.8
2024Dec 31, 20243.5×+0.8
2023Dec 29, 20232.7×−0.2
2022Dec 30, 20222.9×−0.1
2021Dec 31, 20213.0×+1.2
2020Dec 31, 20201.8×−0.4
2019Dec 31, 20192.2×+0.6
2018Dec 31, 20181.6×−0.8
2017Dec 29, 20172.4×−0.9
2016Dec 30, 20163.3×−0.1
2015Dec 31, 20153.5×+0.5
2014Dec 31, 20143.0×−0.0
2013Dec 31, 20133.0×+1.1
2012Dec 31, 20121.9×+0.4
2011Dec 30, 20111.5×−0.6
2010Dec 31, 20102.0×–

More Prestige Consumer Healthcare figures

See a number that looks wrong?